How do flu and COVID affect older lungs?
Aging-linked inflammation may worsen infections
A new line of research is focused on why influenza and COVID-19 tend to be more severe in older adults. The explanation emphasizes aging lungs as a key driver of an immune response that can spiral out of control after infection begins.
According to the story, aged lung tissue appears to contribute to “runaway inflammation,” turning what might otherwise be an acute respiratory infection into a more dangerous inflammatory cascade. In other words, the problem isn’t only that viruses are more difficult to fight; it’s also that the body’s early reaction—shaped by age—can amplify harm.
Why this matters
This matters for two main reasons:
- Treatment targets could shift. If the severity depends partly on inflammation dynamics, therapies that dampen the damaging immune response early could help alongside antiviral approaches.
- Risk stratification may improve. If clinicians can identify which inflammatory patterns mark patients likely to worsen, they could intervene sooner.
What’s missing
The snippet does not provide which inflammatory pathways are responsible, how they were measured, or whether any specific drug candidates were tested. Still, it highlights a host-driven mechanism that may help unify why two different viruses produce similar age-related outcomes.
As follow-up studies arrive, the central question will likely be whether interventions that adjust lung-triggered inflammation can reduce hospitalization rates and complications in the elderly.